A detailed review of a 6-month clinical trial further reinforces strong experimental evidence that a ketogenic diet may offer ...

A new analysis provides substantial evidence that paramagnetic rim lesions drive disability in MS and are targetable with a ...

Neffy 1 mg is the “first significant innovation” for epinephrine delivery in small children aged 4 years and up in over 35 ...

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults. The approval was supported by data from th ...

Genentech, a Roche Group company(OTCQX:RHHBY) said on Wednesday that the U.S. FDA accepted the company’s supplemental ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) for Gazyva®/Gazyvaro® ...

An in-depth analysis of 50+ companies and 65+ pipeline drugs shaping the Molecular Glue market. The report covers therapeutics assessment by product type, development stage, route of administration, ...

US FDA accepts Roche’s Gazyva/Gazyvaro sBLA for the treatment of lupus nephritis: Basel Thursday, March 6, 2025, 09:00 Hrs [IST] Roche announced that the US Food and Drug Admini ...

Omalizumab superior to oral immunotherapy for multifood allergy, and most patients consume allergy-triggering foods after gaining tolerance.

A former Stanford employee is scheduled to be sentenced this July after having allegedly altered breast cancer research data more than 10 years ago.

For select risk-enhanced individuals at intermediate risk of coronary artery disease (CAD), researchers found a way to ...

DelveInsight's Interferons Market Insights report provides the current and forecast market analysis, individual leading ...